Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25084410 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Carla Di Chio und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres, 98166 Mess…. Hauptthemen laut MEDLINE: Cysteine Proteinase Inhibitors, Nitriles, Plasmodium falciparum, Trypanosoma brucei rhodesiense. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRIN2022_PNRR, PRIN_2022PNRR_P2022KCW3L.
Abstract (Originalsprache)
In recent decades, neglected tropical diseases and poverty-related diseases have become a serious health problem worldwide. Among these pathologies, human African trypanosomiasis, and malaria present therapeutic problems due to the onset of resistance, toxicity problems and the limited spectrum of action. In this drug discovery process, rhodesain and falcipain-2, of Trypanosoma brucei rhodesiense and Plasmodium falciparum, are currently considered the most promising targets for the development of novel antitrypanosomal and antiplasmodial agents, respectively. Therefore, in our study we identified a novel lead-like compound, i.e., inhibitor 2b, which we proved to be active against both targets, with a Ki = 5.06 µM towards rhodesain and an IC50 = 40.43 µM against falcipain-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres, 98166 Messina, Italy.
- Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania Luigi Vanvitelli, Via Vivaldi 43, 81100 Caserta, Italy.
- Institute of Organic Chemistry & Macromolecular Chemistry, Friedrich Schiller University of Jena, Humboldtstraße, 10, DE 07743 Jena, Germany.
- Institute of Pharmacy and Biochemistry, University of Mainz, Staudingerweg 5, DE 55128 Mainz, Germany.
- Department of Medicine, San Francisco General Hospital, University of California, 1001 Potrero Avenue, San Francisco, CA 94110, USA.
ORCID-Profile: Santo Previti, Benito Natale, Sandro Cosconati, Marta Bogacz, Maria Zappalà, Roberta Ettari
Förderung
- PRIN2022_PNRR
- PRIN_2022PNRR_P2022KCW3L
Zitieren
APA
Di Chio, C., Starvaggi, J., Totaro, N., Previti, S., Natale, B., Cosconati, S., Bogacz, M., Schirmeister, T., Legac, J., Rosenthal, P. J., Zappalà, M., & Ettari, R. (2024). Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084410
Vancouver
Di Chio C, Starvaggi J, Totaro N, Previti S, Natale B, Cosconati S, et al. Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084410
BibTeX
@article{DiChio2024,
author = {Di Chio, Carla and Starvaggi, Josè and Totaro, Noemi and Previti, Santo and Natale, Benito and Cosconati, Sandro and Bogacz, Marta and Schirmeister, Tanja and Legac, Jenny and Rosenthal, Philip J and Zappalà, Maria and Ettari, Roberta},
title = {Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25084410}
}
EUVIMED